Somak Chatterjee

4PUBLICATIONS
60CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Oct 01, 2026
FDA Approval Summary: Epcoritamab with Lenalidomide and Rituximab for Relapsed or Refractory Follicular Lymphoma.

|Jan 14, 2025
FDA Approval Summary: Tovorafenib for Relapsed or Refractory BRAF-Altered Pediatric Low-Grade Glioma.

Sonia Singh, Diana Bradford, Somak Chatterjee

|Apr 06, 2023
FDA Approval Summary: Amivantamab for the Treatment of Patients with Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations.

Katie Chon, Erin Larkins, Somak Chatterjee

|Oct 07, 2022
FDA Approval Summary: Pemigatinib for Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma with FGFR2 Fusion or Other Rearrangement.

Timil H Patel, Leigh Marcus, M Naomi Horiba

Pageof 1

Frequent Collaborators

3 joint publications

Rosane Charlab

3 joint publications

Jiang Liu

2 joint publications

Stephanie L Aungst

2 joint publications

Jielin Sun